New York-based Delcath Systems, a developer of medical devices used in cancer treatment, has appointed David McDonald chief financial officer, effective immediately.
McDonald named CFO at Delcath Systems
McDonald, 49, replaces Paul Feinstein, who resigned in December 2008 to pursue other interests, according to a company news release. McDonald was most recently senior vice president of business development for devicemaker AngioDynamics.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.